Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Johnson & Johnson trades at a higher valuation with growing sales, while Pfizer's dividend yield is near 6% as patents expire from 2026 through 2030.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

Nasdaq 100 Movers: SNDK, HONIV

In early trading on Monday, shares of Honeywell International topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.5%.

More from Monday 12 October →